Lavrik Inna N, Mock Thomas, Golks Alexander, Hoffmann Julia C, Baumann Simone, Krammer Peter H
Division of Immunogenetics, Tumor Immunology Program, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
J Biol Chem. 2008 Sep 26;283(39):26401-8. doi: 10.1074/jbc.M800823200. Epub 2008 Jul 17.
Stimulation of CD95 (APO-1/Fas) by its natural ligand CD95L (APO-1L/FasL) leads to the formation of the death-inducing signaling complex. Here we report that upon CD95 stimulation in several T and B cell lines, a novel signaling complex is formed, which we term complex II. Complex II is composed of the death effector domain proteins as follows: procaspase-8a/b, three isoforms of c-FLIP (c-FLIP(L), c-FLIP(S), c-FLIP(R)), and FADD. Notably, complex II does not contain CD95. Based on our findings we suggest that CD95 signaling includes two steps. The first step involves formation of the death-inducing signaling complex at the cell membrane. The second step involves formation of the cytosolic death effector domain protein-containing complex that may play an important role in amplification of caspase activation.
其天然配体CD95L(APO-1L/FasL)对CD95(APO-1/Fas)的刺激会导致死亡诱导信号复合物的形成。在此我们报告,在几种T细胞和B细胞系中进行CD95刺激后,会形成一种新型信号复合物,我们将其命名为复合物II。复合物II由以下死亡效应结构域蛋白组成:procaspase-8a/b、c-FLIP的三种同工型(c-FLIP(L)、c-FLIP(S)、c-FLIP(R))和FADD。值得注意的是,复合物II不包含CD95。基于我们的发现,我们认为CD95信号传导包括两个步骤。第一步涉及在细胞膜上形成死亡诱导信号复合物。第二步涉及形成可能在半胱天冬酶激活的放大过程中起重要作用的含胞质死亡效应结构域蛋白的复合物。